These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15651142)

  • 21. Drug-eluting coronary stents.
    Alarcón JA; Arribas JM; Ruiz V
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16319393
    [No Abstract]   [Full Text] [Related]  

  • 22. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting coronary stents.
    Waksman R; Wolfram RM
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320451
    [No Abstract]   [Full Text] [Related]  

  • 24. Are drug-eluting stents a panacea for patients with coronary heart disease?
    Schofer J; Schlüter M
    Lancet; 2004 Aug 14-20; 364(9434):558-9. PubMed ID: 15313338
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug eluting stents: case study in the acceptance of a new medical technology.
    Klein LW; Hodgson JM;
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):528-30. PubMed ID: 15789397
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment and prevention of restenosis after percutaneous coronary intervention. Balloons, stents, radioactive rays and drug-releasing stents].
    Maeng M; Thuesen L; Andersen HR
    Ugeskr Laeger; 2005 Aug; 167(33):3030-2. PubMed ID: 16109244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 29. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
    Elezi S; Dibra A; Mehilli J; Pache J; Wessely R; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Oct; 48(7):1304-9. PubMed ID: 17010786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
    Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting coronary stents.
    Czupryniak L; Pawlowski M; Loba J
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320453
    [No Abstract]   [Full Text] [Related]  

  • 35. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar].
    Hansen PR
    Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
    Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.